Cargando…
PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430313/ http://dx.doi.org/10.1097/01.HS9.0000974300.64022.c0 |
| _version_ | 1785090933171159040 |
|---|---|
| author | Parovichnikova, Elena Lukianova, Irina Galtzeva, Irina Kashlakova, Anastasiya Fidarova, Zalina Aleshina, Olga Kuzmina, Larisa Troitskaya, Vera Drokov, Mikhail Sokolov, Andrey Bondarenko, Sergej Samoilova, Olga Grishunina, Mariya Konstantinova, Tatiana Sveshnikova, Yuliya Minaeva, Natalia Zinina, Elena Lapin, Valerij Kaplanov, Kamil Gritsaev, Sergej Gribanova, Elena Dvirnyk, Valentina Obukhova, Tatiana Sudarikov, Andrej Chabaeva, Yuliya |
| author_facet | Parovichnikova, Elena Lukianova, Irina Galtzeva, Irina Kashlakova, Anastasiya Fidarova, Zalina Aleshina, Olga Kuzmina, Larisa Troitskaya, Vera Drokov, Mikhail Sokolov, Andrey Bondarenko, Sergej Samoilova, Olga Grishunina, Mariya Konstantinova, Tatiana Sveshnikova, Yuliya Minaeva, Natalia Zinina, Elena Lapin, Valerij Kaplanov, Kamil Gritsaev, Sergej Gribanova, Elena Dvirnyk, Valentina Obukhova, Tatiana Sudarikov, Andrej Chabaeva, Yuliya |
| author_sort | Parovichnikova, Elena |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430313 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104303132023-08-17 PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60 Parovichnikova, Elena Lukianova, Irina Galtzeva, Irina Kashlakova, Anastasiya Fidarova, Zalina Aleshina, Olga Kuzmina, Larisa Troitskaya, Vera Drokov, Mikhail Sokolov, Andrey Bondarenko, Sergej Samoilova, Olga Grishunina, Mariya Konstantinova, Tatiana Sveshnikova, Yuliya Minaeva, Natalia Zinina, Elena Lapin, Valerij Kaplanov, Kamil Gritsaev, Sergej Gribanova, Elena Dvirnyk, Valentina Obukhova, Tatiana Sudarikov, Andrej Chabaeva, Yuliya Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430313/ http://dx.doi.org/10.1097/01.HS9.0000974300.64022.c0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Parovichnikova, Elena Lukianova, Irina Galtzeva, Irina Kashlakova, Anastasiya Fidarova, Zalina Aleshina, Olga Kuzmina, Larisa Troitskaya, Vera Drokov, Mikhail Sokolov, Andrey Bondarenko, Sergej Samoilova, Olga Grishunina, Mariya Konstantinova, Tatiana Sveshnikova, Yuliya Minaeva, Natalia Zinina, Elena Lapin, Valerij Kaplanov, Kamil Gritsaev, Sergej Gribanova, Elena Dvirnyk, Valentina Obukhova, Tatiana Sudarikov, Andrej Chabaeva, Yuliya PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60 |
| title | PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60 |
| title_full | PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60 |
| title_fullStr | PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60 |
| title_full_unstemmed | PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60 |
| title_short | PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60 |
| title_sort | pb1866: is allo-hsct in cr1 necessary for aml patients with mrd negativity achieved after the first induction course? russian prospective multicenter randomized trial in aml patients under the age of 60 |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430313/ http://dx.doi.org/10.1097/01.HS9.0000974300.64022.c0 |
| work_keys_str_mv | AT parovichnikovaelena pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT lukianovairina pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT galtzevairina pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT kashlakovaanastasiya pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT fidarovazalina pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT aleshinaolga pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT kuzminalarisa pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT troitskayavera pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT drokovmikhail pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT sokolovandrey pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT bondarenkosergej pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT samoilovaolga pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT grishuninamariya pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT konstantinovatatiana pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT sveshnikovayuliya pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT minaevanatalia pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT zininaelena pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT lapinvalerij pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT kaplanovkamil pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT gritsaevsergej pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT gribanovaelena pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT dvirnykvalentina pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT obukhovatatiana pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT sudarikovandrej pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 AT chabaevayuliya pb1866isallohsctincr1necessaryforamlpatientswithmrdnegativityachievedafterthefirstinductioncourserussianprospectivemulticenterrandomizedtrialinamlpatientsundertheageof60 |